同卵与异卵双胞胎:胰岛自身免疫及1型糖尿病发生的风险与相关因素
基于TrialNet Pathway to Prevention研究(N=48,026)2004–2015年筛查数据,随访17,226例(同卵双胞胎157例、异卵双胞胎283例、全同胞16,786例)中位2.1年,分析胰岛自身抗体阳性与1型糖尿病的发生及遗传与环境因素影响。结果显示同卵双胞胎筛查时GADA、IA-2A、IAA阳性率均高于异卵双胞胎或全同胞(均P<0.0001);初始自身抗体阳性的同卵双胞胎3年内糖尿病风险为69%,而初始抗体阴性者仅1.5%。
要点
- 初始自身抗体阳性的同卵双胞胎3年糖尿病风险达69%,初始抗体阴性者仅1.5%。
- 异卵双胞胎中初始多抗体阳性者3年风险72%,单抗体阳性13%,抗体阴性0%。
- 年轻、男性及遗传因素是自身抗体表达的显著风险因素(均P≤0.03)。
核心结论
- 初始多抗体或单抗体阳性的同卵双胞胎及多抗体阳性的异卵双胞胎3年内1型糖尿病风险高。
- 遗传易感性、年龄和男性性别是双胞胎中自身抗体阳性的显著风险因素。
研究设计与样本
- 来自TrialNet Pathway to Prevention研究(N=48,026)2004至2015年筛查胰岛自身抗体(GADA、IA-2A、IAA)。
- 其中17,226例(同卵双胞胎157例、异卵双胞胎283例、全同胞16,786例)随访自身抗体阳性或1型糖尿病,中位随访2.1年。
主要发现
- 筛查时同卵双胞胎GADA、IA-2A和IAA阳性率均高于异卵双胞胎或全同胞(均P<0.0001)。
- 年轻、男性及遗传因素是IA-2A、IAA、一个及以上自身抗体阳性及两个及以上自身抗体阳性的显著因素(均P≤0.03)。
- 初始自身抗体阳性的同卵双胞胎3年糖尿病风险为69%,初始抗体阴性同卵双胞胎为1.5%。
- 异卵双胞胎3年1型糖尿病风险:初始多抗体阳性72%,单抗体阳性13%,抗体阴性0%。
- 全同胞3年1型糖尿病风险:多抗体阳性47%,单抗体阳性12%,初始抗体阴性0.5%。
关键数值与推荐
- 初始自身抗体阳性同卵双胞胎3年糖尿病风险69%,初始抗体阴性同卵双胞胎1.5%。
- 异卵双胞胎3年1型糖尿病风险:多抗体阳性72%,单抗体阳性13%,抗体阴性0%。
- 全同胞3年1型糖尿病风险:多抗体阳性47%,单抗体阳性12%,初始抗体阴性0.5%。
临床怎么用
- 对双胞胎中初始自身抗体阳性者,尤其同卵双胞胎及多抗体阳性者,3年内1型糖尿病风险高,需密切监测。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There are variable reports of risk of concordance for progression to islet autoantibodies and type 1 diabetes in identical twins after one twin is diagnosed. We examined development of positive autoantibodies and type 1 diabetes and the effects of genetic factors and common environment on autoantibody positivity in identical twins, nonidentical twins, and full siblings. RESEARCH DESIGN AND METHODS: Subjects from the TrialNet Pathway to Prevention Study (N = 48,026) were screened from 2004 to 2015 for islet autoantibodies (GAD antibody [GADA], insulinoma-associated antigen 2 [IA-2A], and autoantibodies against insulin [IAA]). Of these subjects, 17,226 (157 identical twins, 283 nonidentical twins, and 16,786 full siblings) were followed for autoantibody positivity or type 1 diabetes for a median of 2.1 years. RESULTS: At screening, identical twins were more likely to have positive GADA, IA-2A, and IAA than nonidentical twins or full siblings (all P < 0.0001). Younger age, male sex, and genetic factors were significant factors for expression of IA-2A, IAA, one or more positive autoantibodies, and two or more positive autoantibodies (all P ≤ 0.03). Initially autoantibody-positive identical twins had a 69% risk of diabetes by 3 years compared with 1.5% for initially autoantibody-negative identical twins. In nonidentical twins, type 1 diabetes risk by 3 years was 72% for initially multiple autoantibody-positive, 13% for single autoantibody-positive, and 0% for initially autoantibody-negative nonidentical twins. Full siblings had a 3-year type 1 diabetes risk of 47% for multiple autoantibody-positive, 12% for single autoantibody-positive, and 0.5% for initially autoantibody-negative subjects. CONCLUSIONS: Risk of type 1 diabetes at 3 years is high for initially multiple and single autoantibody-positive identical twins and multiple autoantibody-positive nonidentical twins. Genetic predisposition, age, and male sex are significant risk factors for development of positive autoantibodies in twins.
引用
- Triolo TM, Fouts A, Pyle L, et al. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes. Diabetes Care. 2018. PMID: 30061316. doi:10.2337/dc18-0288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。